Johnson & Johnson's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Current-Deferred-Revenue" stands at 34.72 Billion United States Dollars as of 09/30/2024, the highest value at least since 03/31/2011, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 1,097.76 percent compared to the value the year prior.
The 1 year change in percent is 1,097.76.
The 3 year change in percent is 226.16.
The 5 year change in percent is 351.18.
The 10 year change in percent is 807.32.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Current Deferred Revenue | 905,699,262,464.00 |
![]() | AbbVie Inc - Current Deferred Revenue | 399,570,305,024.00 |
![]() | Roche Holding AG - Current Deferred Revenue | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Current Deferred Revenue | 280,205,508,085.11 |
![]() | Novartis AG - Current Deferred Revenue | 255,096,620,580.91 |